About this trial
This study is testing whether electronic surveys can help patients with advanced cancer report their symptoms and care needs so their doctors can connect them to palliative/supportive care services sooner. The goal is to see if this approach can make it easier for patients to get support for symptoms, quality of life, and other needs during cancer treatment.
Eligibility criteria
Qualifiers
Age ≥18 years.
Diagnosis of unresectable or metastatic, incurable thoracic, gastrointestinal, or breast solid tumor.
Receiving active cancer-directed therapy longitudinally in the outpatient oncology clinic and expected to continue treatment.
Disqualifiers
Members of vulnerable populations, including infants, minors, individuals unable to provide informed consent, and those who are incarcerated or imprisoned at the time of enrollment.
Already established with palliative care, defined as having a scheduled future palliative care appointment, a pending referral, or a visit with palliative care within the past 90 days.
Unable to provide informed consent in English.
Cognitive impairment that, in the judgment of the treating clinician, would preclude study participation.
Trial design
Treatments tested in this trial
- ePRO-Directed Referral and Navigation to Palliative/Supportive Care
- ePRO Symptom Monitoring with Usual Palliative Care Referral
Treatment groups
Sponsors and collaborators
Dartmouth-Hitchcock Medical Center
Lead sponsor
American Cancer Society (ACS)
Collaborator